Cargando…
A risk-based approach to experimental early phase clinical trials during the COVID-19 pandemic
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7324104/ https://www.ncbi.nlm.nih.gov/pubmed/32615107 http://dx.doi.org/10.1016/S1470-2045(20)30339-9 |
| _version_ | 1783551881356771328 |
|---|---|
| author | Tiu, Crescens Shinde, Rajiv Yap, Christina Rao Baikady, Bindumalini Banerji, Udai Minchom, Anna R de Bono, Johann S Lopez, Juanita S |
| author_facet | Tiu, Crescens Shinde, Rajiv Yap, Christina Rao Baikady, Bindumalini Banerji, Udai Minchom, Anna R de Bono, Johann S Lopez, Juanita S |
| author_sort | Tiu, Crescens |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7324104 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-73241042020-06-30 A risk-based approach to experimental early phase clinical trials during the COVID-19 pandemic Tiu, Crescens Shinde, Rajiv Yap, Christina Rao Baikady, Bindumalini Banerji, Udai Minchom, Anna R de Bono, Johann S Lopez, Juanita S Lancet Oncol Article Elsevier Ltd. 2020-07 2020-06-29 /pmc/articles/PMC7324104/ /pubmed/32615107 http://dx.doi.org/10.1016/S1470-2045(20)30339-9 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Tiu, Crescens Shinde, Rajiv Yap, Christina Rao Baikady, Bindumalini Banerji, Udai Minchom, Anna R de Bono, Johann S Lopez, Juanita S A risk-based approach to experimental early phase clinical trials during the COVID-19 pandemic |
| title | A risk-based approach to experimental early phase clinical trials during the COVID-19 pandemic |
| title_full | A risk-based approach to experimental early phase clinical trials during the COVID-19 pandemic |
| title_fullStr | A risk-based approach to experimental early phase clinical trials during the COVID-19 pandemic |
| title_full_unstemmed | A risk-based approach to experimental early phase clinical trials during the COVID-19 pandemic |
| title_short | A risk-based approach to experimental early phase clinical trials during the COVID-19 pandemic |
| title_sort | risk-based approach to experimental early phase clinical trials during the covid-19 pandemic |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7324104/ https://www.ncbi.nlm.nih.gov/pubmed/32615107 http://dx.doi.org/10.1016/S1470-2045(20)30339-9 |
| work_keys_str_mv | AT tiucrescens ariskbasedapproachtoexperimentalearlyphaseclinicaltrialsduringthecovid19pandemic AT shinderajiv ariskbasedapproachtoexperimentalearlyphaseclinicaltrialsduringthecovid19pandemic AT yapchristina ariskbasedapproachtoexperimentalearlyphaseclinicaltrialsduringthecovid19pandemic AT raobaikadybindumalini ariskbasedapproachtoexperimentalearlyphaseclinicaltrialsduringthecovid19pandemic AT banerjiudai ariskbasedapproachtoexperimentalearlyphaseclinicaltrialsduringthecovid19pandemic AT minchomannar ariskbasedapproachtoexperimentalearlyphaseclinicaltrialsduringthecovid19pandemic AT debonojohanns ariskbasedapproachtoexperimentalearlyphaseclinicaltrialsduringthecovid19pandemic AT lopezjuanitas ariskbasedapproachtoexperimentalearlyphaseclinicaltrialsduringthecovid19pandemic AT tiucrescens riskbasedapproachtoexperimentalearlyphaseclinicaltrialsduringthecovid19pandemic AT shinderajiv riskbasedapproachtoexperimentalearlyphaseclinicaltrialsduringthecovid19pandemic AT yapchristina riskbasedapproachtoexperimentalearlyphaseclinicaltrialsduringthecovid19pandemic AT raobaikadybindumalini riskbasedapproachtoexperimentalearlyphaseclinicaltrialsduringthecovid19pandemic AT banerjiudai riskbasedapproachtoexperimentalearlyphaseclinicaltrialsduringthecovid19pandemic AT minchomannar riskbasedapproachtoexperimentalearlyphaseclinicaltrialsduringthecovid19pandemic AT debonojohanns riskbasedapproachtoexperimentalearlyphaseclinicaltrialsduringthecovid19pandemic AT lopezjuanitas riskbasedapproachtoexperimentalearlyphaseclinicaltrialsduringthecovid19pandemic |